| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,769 |
8,200 |
$1.51M |
| D9999 |
Unspecified adjunctive procedure, by report |
2,865 |
2,654 |
$731K |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,505 |
757 |
$215K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,476 |
1,174 |
$203K |
| D0140 |
Limited oral evaluation - problem focused |
457 |
430 |
$112K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
1,854 |
1,239 |
$111K |
| 90832 |
Psychotherapy, 30 minutes with patient |
402 |
202 |
$81K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
593 |
510 |
$71K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
52 |
51 |
$12K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
35 |
33 |
$7K |
| 0011A |
|
182 |
178 |
$3K |
| 0012A |
|
146 |
140 |
$3K |
| 99215 |
Prolong outpt/office vis |
20 |
18 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
144 |
119 |
$1K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,240 |
618 |
$985.76 |
| 0013A |
|
24 |
24 |
$692.85 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
34 |
26 |
$591.41 |
| 92552 |
|
163 |
134 |
$41.34 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
15 |
14 |
$5.83 |
| 91301 |
|
360 |
348 |
$0.21 |
| 3074F |
|
2,003 |
1,618 |
$0.00 |
| 1036F |
|
1,752 |
1,345 |
$0.00 |
| 3079F |
|
369 |
314 |
$0.00 |
| 1125F |
|
574 |
470 |
$0.00 |
| 1126F |
|
2,297 |
1,863 |
$0.00 |
| 3008F |
|
2,574 |
2,007 |
$0.00 |
| 1034F |
|
136 |
90 |
$0.00 |
| 3075F |
|
71 |
60 |
$0.00 |
| 90651 |
|
17 |
17 |
$0.00 |
| 96127 |
|
35 |
29 |
$0.00 |
| 3078F |
|
1,904 |
1,549 |
$0.00 |
| 3725F |
|
1,681 |
1,266 |
$0.00 |
| 1160F |
|
1,409 |
1,109 |
$0.00 |
| 1159F |
|
1,407 |
1,109 |
$0.00 |
| 90461 |
|
34 |
27 |
$0.00 |
| 3077F |
|
68 |
56 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
14 |
14 |
$0.00 |
| 99173 |
|
135 |
119 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
13 |
13 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
14 |
13 |
$0.00 |